Results 61 to 70 of about 44,306 (276)

Efficacy of Human Papillomavirus Vaccines for Recalcitrant Anogenital and Oral Warts

open access: yesJournal of Clinical Medicine, 2023
Human papillomavirus (HPV) vaccines are preventive measures to decrease HPV infection rates. Knowledge of their efficacy as treatment options for anogenital warts (AGWs) and oral warts (OWs) is limited.
G. Ciccarese   +5 more
semanticscholar   +1 more source

Papillomavirus Infection of the Anogenital Region: Correlation Between Histology, Clinical Picture, and Virus Type. Proposal of a New Nomenclature [PDF]

open access: yes, 1985
The clinical and histologic picture of 84 anogenital condylomatous and condyloma-like lesions of both sexes were analyzed in an effort to establish a correlation to the different papillomavirus (PV) types.
Geleijnse, Johanna M.   +4 more
core   +1 more source

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)

open access: yesBMC Medical Research Methodology, 2018
Background Anogenital warts are the second most common sexually transmitted infection diagnosed in sexual health services in England. About 90% of genital warts are caused by human papillomavirus (HPV) types 6 or 11, and half of episodes diagnosed are ...
Macey L. Murray   +11 more
doaj   +1 more source

Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata. [PDF]

open access: yes, 2013
BACKGROUND: The low-risk human papillomavirus types 6 and 11 are responsible for approximately 90% of anogenital wart cases, with approximately 190,000 new and recurrent cases reported in the UK in 2010.
Ball, Siolian LR   +7 more
core   +4 more sources

Prevalence, incidence and correlates of low risk HPV infection and anogenital warts in a cohort of women living with HIV in Burkina Faso and South Africa. [PDF]

open access: yes, 2018
OBJECTIVE: To report the prevalence and incidence of low-risk human papillomavirus infection (LR-HPV) and anogenital warts (AGW) among women living with HIV (WLHIV) in Burkina Faso (BF) and South Africa (SA), and to explore HIV-related factors associated
Chikandiwa, Admire   +12 more
core   +14 more sources

Nonsexual Transmission of Anogenital Warts in Children: A Retrospective Analysis

open access: yesThe Scientific World Journal, 2007
The purpose was to evaluate the prevalence of sexual abuse in patients who were referred to a pediatric gynecologist for evaluation based on the clinical findings of anogenital warts.
Valerie Jones   +2 more
doaj   +1 more source

Detection and quantitation of HPV in anogenital and oral tissues and fluids of HIV-positive individuals by real-time PCR [PDF]

open access: yes, 2010
Human papillomaviruses (HPV) remain a serious world health problem due to their association with anogenital and oral cancers and warts. While over 100 HPV types have been identified, only a subset is associated with malignancy.
William T Seaman   +8 more
core   +2 more sources

Photogallery. Anogenital (venereal) warts

open access: yesRussian Journal of Skin and Venereal Diseases, 2022
Anogenital warts are caused by the human papillomavirus (most commonly types 6 and 11, giant condylomas ― types 16 and 18) and are exophytic and endophytic growths on the skin and mucous membranes of the genital and perianal areas. There is no generally accepted classification, but based on clinical manifestations, there are: acute condylomas, papular,
Valery V. Dubensky   +1 more
openaire   +1 more source

Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy

open access: yesVaccines, 2021
Variable intralesional immunotherapies have recently been proposed as a means of achieving a successful eradication of recurrent and recalcitrant human papillomavirus (HPV)-induced cutaneous and anogenital warts.
Noha M. Hammad   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy